Scatena, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 3.319
EU - Europa 2.841
AS - Asia 2.397
SA - Sud America 446
AF - Africa 61
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.074
Nazione #
US - Stati Uniti d'America 3.220
SG - Singapore 981
CN - Cina 699
DE - Germania 616
RU - Federazione Russa 537
SE - Svezia 369
BR - Brasile 352
UA - Ucraina 319
FR - Francia 188
VN - Vietnam 186
IT - Italia 172
PL - Polonia 154
GB - Regno Unito 121
IE - Irlanda 118
TR - Turchia 105
FI - Finlandia 97
IN - India 92
ID - Indonesia 79
CA - Canada 56
JP - Giappone 56
BD - Bangladesh 38
HK - Hong Kong 34
AR - Argentina 28
ES - Italia 26
IQ - Iraq 25
BE - Belgio 23
NL - Olanda 22
MX - Messico 21
KR - Corea 19
VE - Venezuela 17
ZA - Sudafrica 16
MA - Marocco 14
CO - Colombia 11
EC - Ecuador 11
PK - Pakistan 11
RO - Romania 10
AE - Emirati Arabi Uniti 8
AT - Austria 8
CH - Svizzera 8
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
CL - Cile 7
IL - Israele 7
IR - Iran 7
UZ - Uzbekistan 7
KE - Kenya 6
PT - Portogallo 6
PY - Paraguay 6
AU - Australia 5
BY - Bielorussia 5
EG - Egitto 5
MY - Malesia 5
PE - Perù 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LT - Lituania 4
DK - Danimarca 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GN - Guinea 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
ME - Montenegro 1
Totale 9.062
Città #
Singapore 501
Chandler 406
Ashburn 390
San Jose 289
Jacksonville 157
Warsaw 150
Beijing 125
San Mateo 116
Dublin 113
Nanjing 106
New York 90
Wilmington 84
The Dalles 72
Woodbridge 69
Ann Arbor 68
Los Angeles 67
Houston 66
Jakarta 65
Izmir 62
Lauterbourg 60
Fairfield 58
Hefei 58
Dearborn 57
Ho Chi Minh City 52
Boston 49
Hanoi 46
Lawrence 45
Seattle 44
Tokyo 44
Redmond 43
Chicago 38
Cattolica 37
São Paulo 34
Moscow 33
Frankfurt am Main 32
Hong Kong 31
Helsinki 28
Bremen 27
Mountain View 25
Shanghai 25
Cambridge 23
Kunming 23
Redwood City 23
Boardman 21
Montreal 21
Munich 21
Nürnberg 20
Zhengzhou 20
Kent 19
Detroit 18
Milan 18
Nanchang 18
Princeton 18
Hangzhou 17
Shenyang 17
London 16
Rome 16
Brussels 15
Hebei 15
Dallas 14
Guangzhou 14
Santa Clara 14
Lancaster 13
Toronto 13
University Park 13
Brooklyn 12
Marseille 12
Philadelphia 12
Pune 12
Buffalo 11
Jiaxing 11
Seoul 11
Changsha 10
Johannesburg 10
Orem 10
Atlanta 9
Baghdad 9
Belo Horizonte 9
Dhaka 9
Paris 9
Tianjin 9
Turku 9
Edinburgh 8
Cardiff 7
Da Nang 7
Düsseldorf 7
Haiphong 7
Lanzhou 7
Simi Valley 7
Tashkent 7
Chengdu 6
Chennai 6
Curitiba 6
Indiana 6
Istanbul 6
Madrid 6
Manchester 6
Memphis 6
Norwalk 6
Phoenix 6
Totale 4.593
Nome #
FUNCTIONAL ALTERATIONS IN ADULT AND FETAL HEMOGLOBIN SASSARI ASP-ALPHA-126(H9) -] HIS - THE ROLE OF ALPHA(1)ALPHA(2) CONTACT 604
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing 407
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 206
CA 19-9: Biochemical and Clinical Aspects 200
Advances in Cancer Biomarkers - From biochemistry to clinic for a critical revision 197
Advances in Cancer Stem Cell Biology 192
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 188
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 186
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 184
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 184
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 176
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 174
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence 170
Prognostic value of the reactive oxygen species in severe sepsis and septic shock patients: a-pilot study 169
Advances in Mitochondrial Medicine 162
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 161
An update on pharmacological approaches to neurodegenerative diseases. 160
A Critical Approach to Clinical Biochemistry of Chromogranin A 160
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 156
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 155
Immunological role of IgG subclasses 154
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 153
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 152
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 151
CA 19-9: Biochemical and Clinical Aspects 148
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 146
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 140
Oxygen transport by Fetal Bovine Hemoglobin 136
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 135
Cancer stem cells: the development of new cancer therapeutics 131
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 131
Cancer Stem Cells: An Innovative Therapeutic Approach 131
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 128
Immunological role of IgG subclasses 127
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 126
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 124
The role of CA 125 as tumor marker: biochemical and clinical aspects 123
A critical approach to clinical biochemistry of Chromogranin A 122
Cancer Biomarkers: A Status Quo 121
CA 19-9: Biochemical and Clinical Aspects 121
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 119
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 117
EFFECTS OF GEMFIBROZIL ON THE OXYGEN-TRANSPORT PROPERTIES OF ERYTHROCYTES 115
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation growth inhibition and terminal cell differentiation 109
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 109
Glycolytic enzyme inhibitors in cancer treatment. 108
Resveratrol treatment induces redox stress in red blood cells: a possible role of caspase 3 in metabolism and anion transport 108
Cancer Stem Cells: A Revisitation of the “Anaplasia” Concept. In Advances in Cancer Stem Cell Biology 107
SEPARATION OF REDUCED AND OXIDIZED GLUTATHIONE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY 104
THE MULTIPLE FUNCTIONS OF HEMOGLOBIN 101
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 100
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies 100
Mitochondrial respiration and differentiation 99
PHYSIOLOGICAL RELEVANCE OF THE OVERALL DELTA-H OF OXYGEN BINDING TO FETAL HUMAN HEMOGLOBIN 95
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 94
Cellular respiration and dedifferentiation 93
Mitochondria and drugs 91
The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron. 91
Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation 84
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 82
Cytotoxicity of a new endodontic filling material 82
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 78
Nitroflurbiprofen (NicOx). 69
Totale 9.146
Categoria #
all - tutte 32.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022567 48 69 9 59 32 24 14 91 17 26 73 105
2022/20231.663 154 191 94 169 94 137 29 118 583 26 52 16
2023/2024458 25 142 5 12 19 75 16 22 5 23 63 51
2024/20251.120 34 25 85 35 98 43 33 74 156 138 189 210
2025/20262.713 421 103 171 279 406 189 531 151 202 173 67 20
Totale 9.146